Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2013 13:55 ET | Source: PolyMedix, Inc.

PolyMedix Announces Results of Special Meeting, Effective Date of Reverse Stock Split

RADNOR, Pa., March 15, 2013 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company developing small-molecule drugs designed to mimic the activity of host defense proteins (HDPs) for...
March 07, 2013 16:12 ET | Source: PolyMedix, Inc.

PolyMedix Announces Proposed Public Offering of Common Stock

RADNOR, Pa., March 7, 2013 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company developing small-molecule drugs designed to mimic the activity of host defense proteins (HDPs) for...
March 06, 2013 07:00 ET | Source: PolyMedix, Inc.

PolyMedix Provides Business Update and Reports Fourth Quarter 2012 Financial Results

RADNOR, Pa., March 6, 2013 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company developing small-molecule drugs designed to mimic the activity of host defense proteins (HDPs) for...
February 07, 2013 08:00 ET | Source: PolyMedix, Inc.

PolyMedix CEO Posts Letter to Shareholders on Its Website

RADNOR, Pa., Feb. 7, 2013 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative therapeutic drugs based on its novel defensin-mimetic technology...
January 30, 2013 16:30 ET | Source: PolyMedix, Inc.

PolyMedix Announces Departure of CEO, Appointment of Interim CEO

RADNOR, Pa., Jan. 30, 2013 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company dedicated to developing novel treatments for infectious diseases with defensin-mimetic...
January 23, 2013 16:30 ET | Source: PolyMedix, Inc.

PolyMedix Engages Investment Banker, Amends Credit Facility

RADNOR, Pa., Jan. 23, 2013 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative therapeutic drugs intended to treat patients with serious...
January 14, 2013 07:00 ET | Source: PolyMedix, Inc.

PolyMedix Defensin-Mimetic Anti-Malaria Data Published in Cell Host and Microbe

RADNOR, Pa., Jan. 14, 2013 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company dedicated to developing novel treatments for infectious diseases with defensin-mimetic...
November 16, 2012 08:32 ET | Source: PolyMedix, Inc.

PolyMedix Announces Successful Meeting With FDA for Brilacidin

RADNOR, Pa., Nov. 16, 2012 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company dedicated to developing novel treatments for infectious diseases with defensin-mimetic...
November 08, 2012 16:36 ET | Source: PolyMedix, Inc.

PolyMedix Reports Third Quarter 2012 Financial Results

RADNOR, Pa., Nov. 8, 2012 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company dedicated to transforming the treatment of infectious diseases with novel defensin-mimetic...
September 19, 2012 07:00 ET | Source: PolyMedix, Inc.

PolyMedix Receives Grant From National Cancer Institute to Study Brilacidin for Oral Mucositis

RADNOR, Pa., Sept. 19, 2012 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative antimicrobial compounds intended to treat a wide range of...